Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Atrophy

3,4-dihydroxyphenylacetic acid has been researched along with Atrophy in 3 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Bregt, DR1
Thomas, TC1
Hinzman, JM1
Cao, T1
Liu, M1
Bing, G1
Gerhardt, GA1
Pauly, JR1
Lifshitz, J1
Lehmann, J1
DeSouza, EB1
Culp, S1
Zaczek, R1
van Kammen, DP1
van Kammen, WB1
Mann, LS1
Seppala, T1
Linnoila, M1

Other Studies

3 other studies available for 3,4-dihydroxyphenylacetic acid and Atrophy

ArticleYear
Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.
    Experimental neurology, 2012, Volume: 234, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atrophy; Brain Injuries; Calcium-Binding Proteins; Carrier

2012
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Annals of the New York Academy of Sciences, 1992, May-11, Volume: 648

    Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atr

1992
Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
    Archives of general psychiatry, 1986, Volume: 43, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Atrophy; Cerebral Cortex; Dopamine; Female; Homov

1986